Latest Breaking News On - Robertw duggan - Page 1 : comparemela.com

First-Line Ivonescimab Improves PFS vs Pembrolizumab in PD-L1+ NSCLC in China

First-Line Ivonescimab Improves PFS vs Pembrolizumab in PD-L1+ NSCLC in China
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

China
Maky-zanganeh
Robertw-duggan
European-commission
Team-summit
Summit-therapeutics

Summit Therapeutics (SMMT): Ivonescimab Beats Pembrolizumab Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC

Summit Therapeutics (SMMT): Ivonescimab Beats Pembrolizumab Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China
Maky-zanganeh
Robertw-duggan
Akeso-inc
Summit-therapeutics-inc
Data-monitoring-committee
Nasdaq
Team-summit
Chief-executive-officer

Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy

Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Canada
United-kingdom
Miami
Florida
United-states
Spain
California
China
Germany
Li-zhang
Zhejiang
Cleveland-clinic

Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in China

Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC in China
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

South-korea
Cleveland-clinic
Florida
United-states
Australia
Spain
United-kingdom
France
Miami
Germany
Canada
Japan

Pulse Biosciences has new CEO, former boss moves to COO spot

Pulse Biosciences has new CEO, former boss moves to COO spot
massdevice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massdevice.com Daily Mail and Mail on Sunday newspapers.

United-states
California
Robertw-duggan
Kevin-danahy
Circulatory-system-medical-devices-advisory-panel
Pulse-biosciences
Cyberkinetics-neurotechnology
System-medical-devices-advisory-panel